Your browser doesn't support javascript.
loading
Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical trial developed by consensus of an international study group. Part two: design of the study.
Bauhofer, A; Lorenz, W; Stinner, B; Rothmund, M; Koller, M; Sitter, H; Celik, I; Farndon, J R; Fingerhut, A; Hay, J M; Lefering, R; Lorijn, R; Nyström, P O; Schäfer, H; Schein, M; Solomkin, J; Troidl, H; Volk, H D; Wittmann, D H; Wyatt, J.
Afiliação
  • Bauhofer A; Institute of Theoretical Surgery, Philipps-University Marburg, Germany. bauhofer@mailer.uni-marburg.de
Inflamm Res ; 50(4): 187-205, 2001 Apr.
Article em En | MEDLINE | ID: mdl-11392607
ABSTRACT
GENERAL

DESIGN:

Presentation of a new type of a study protocol for evaluation of the effectiveness of an immune modifier (rhG-CSF, filgrastim) prevention of postoperative infectious complications and of sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). This part describes the design of the randomised, placebo controlled, double-blinded, single-centre study performed at an university hospital (n = 40 patients for each group).

OBJECTIVE:

The trial design includes the following elements for a prototype protocol * The study population is restricted to patients with colorectal cancer, including a left sided resection and an increased perioperative risk (ASA 3 and 4). * Patients are allocated by random to the control or treatment group. * The double blinding strategy of the trial is assessed by psychometric indices. * An endpoint construct with quality of life (EORTC QLQ-C30) and a recovery index (modified Mc Peek index) are used as primary endpoints. Qualitative analysis of clinical relevance of the endpoints is performed by both patients and doctors. * Statistical analysis uses an area under the curve (AUC) model for improvement of quality of life on leaving hospital and two and six months after operation. A confirmatory statistical model with quality of life as the first primary endpoint in the hierarchic test procedure is used. Expectations of patients and surgeons and the negative affect are analysed by social psychological scales.

CONCLUSION:

This study design differs from other trials on preoperative prophylaxis and postoperative recovery, and has been developed to try a new concept and avoid previous failures.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Projetos de Pesquisa / Neoplasias Colorretais / Ensaios Clínicos Controlados Aleatórios como Assunto / Fator Estimulador de Colônias de Granulócitos / Controle de Infecções Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Inflamm Res Assunto da revista: ALERGIA E IMUNOLOGIA / PATOLOGIA Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Alemanha
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Projetos de Pesquisa / Neoplasias Colorretais / Ensaios Clínicos Controlados Aleatórios como Assunto / Fator Estimulador de Colônias de Granulócitos / Controle de Infecções Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Inflamm Res Assunto da revista: ALERGIA E IMUNOLOGIA / PATOLOGIA Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Alemanha